Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of SCIg as induction and maintenance treatment in CIDP.

This is a protocol.

Published:

9 October 2021

Authors:

Bus SRM, Wieske L, Keddie S, van Schaik IN, Eftimov F

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Bus SRM, Wieske L, Keddie S, van Schaik IN, Eftimov F. Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD014542. DOI: 10.1002/14651858.CD014542.